Showing results (1-10 of 760) with videos related to
Sort By:
Pageof 76
Journal of Molecular and Cellular Cardiology|December 3, 2014
The mitochondrial calcium uniporter: mice can live and die without itJosephine L Harrington, Elizabeth MurphyCurrent Opinion in Cardiology|February 25, 2025
Advances in the management of obesity and heart failure: latest evidence from clinical trialsThomaz Alexandre Costa, Josephine L HarringtonAnnals of Internal Medicine|August 5, 2024
In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 yBelal Suleiman, Christopher B GrangerAnnals of Internal Medicine|March 4, 2024
In adults aged ≥80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 yHarman Yonis, Christopher B GrangerDrugs of Today (Barcelona, Spain : 1998)|May 11, 2005
Pexelizumab: a novel therapy for myocardial ischemia-reperfusionManesh R Patel, Christopher B GrangerAnnals of Internal Medicine|December 5, 2022
In older men, an invitation for comprehensive CV screening did not reduce death at 5.6 yKonstantin A Krychtiuk, Christopher B GrangerReviews in Cardiovascular Medicine|December 28, 2004
Reducing cardiac events after acute coronary syndromesChristopher B Granger, W Douglas WeaverNature Reviews. Cardiology|February 29, 2012
Acute coronary syndromes. Challenging accepted post-MI serum potassium targetsSean van Diepen, Christopher B GrangerAnnals of Internal Medicine|May 2, 2022
In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attackKonstantin A Krychtiuk, Christopher B GrangerAnnals of Internal Medicine|October 19, 2020
In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrelMichael G Nanna, Christopher B GrangerPageof 76